Planning to attend today’s session on claudin-targeted therapies at #AACR26? Gear up by reading “Claudin 18.2 ADCs Demonstrate Early Clinical Promise,” which describes the safety and effectiveness of two agents against gastric and GEJ cancers.
https://
dx.doi.org/10.1158/2159-8
290.CD-NW2025-0069
…